All articles tagged with #randd spending
Pfizer's record sales driven by pandemic vaccine and drug sales are declining as the end of the crisis approaches, prompting CEO Albert Bourla to focus on new drug approvals and deals while being prepared to reduce R&D spending for Covid-19 if necessary.
Apple CEO Tim Cook confirmed that the company has been working on generative AI for years, as part of its significant investment in research and development. Despite criticism that Apple is behind in AI, the company has already integrated advanced machine learning models into products like the iPhone's camera and Siri. While rumors suggest Apple may be developing a ChatGPT-like product internally, it remains uncertain if it will be released. However, Apple is expected to continue advancing its AI technologies across its platforms, with speculation that the developer tool Xcode could be the next target for an AI tool.
MIT CRISPR researcher Feng Zhang and his lab have engineered syringes made by bacteria to deliver potential therapies like toxins that kill cancer cells and gene editors. They developed syringes that can load proteins of their choice and selectively target human cells. Meanwhile, Johnson & Johnson has ended development of its adult RSV vaccine that was in the middle of a 27,200-patient trial, giving up a big slice of what’s expected to be the next multibillion-dollar pharma market. The FDA has approved Emergent BioSolutions’ Narcan brand naloxone nasal spray for over the counter sales.